Intravenous iron therapy in pediatrics: who should get it and when is the right time?

• Published in: Hematology 2023-12, Vol.2023 (1), p.630-635
• Main Authors: Cohen, Clay T, Powers, Jacquelyn M
• Format: Article
• Language: English
• Subjects: Adolescent; Anemia - complications; Anemia, Iron-Deficiency; Child; Child, Preschool; Chronic Disease; Female; Humans; Iron - therapeutic use; Iron Deficiencies; The Iron Revolution
• ISSN: 1520-4391; 1520-4383; 1520-4383
• DOI: 10.1182/hematology.2023000496

Iron-deficiency anemia occurs most commonly in young children due to a low-iron diet and adolescent girls due to menstrual blood loss. However, children with gastrointestinal conditions such as intestinal failure, inflammatory bowel disease, celiac disease, and/or other chronic conditions, including chronic kidney disease and heart failure, also commonly have iron deficiency. Many patients with classic iron-deficiency anemia will improve with oral iron therapy. However, in children who have an incomplete response to oral iron, intravenous iron therapy is increasingly being used. Benefits of intravenous iron therapy include a rapid repletion of iron stores in addition to resolution of anemia, less gastrointestinal side effects, and relief for patients and families struggling with long-term iron supplementation. Indications for first-line therapy with intravenous iron in children with chronic conditions have also increased. Four intravenous iron formulations have approved indications in pediatrics, and many are increasingly used off-label in children as well. Here we discuss the indications and appropriate timing of intravenous iron therapy in children with a wide range of underlying etiologies.